Kitea Health long-term ICP microimplant published in Nature Communications — first discrete chronic brain pressure sensor in humans
Summary
Kitea Health published first-in-human safety and initial efficacy data for their brain pressure microimplant in Nature Communications. The discrete miniaturized ICP sensor was implanted in adults and children with hydrocephalus for long-term intracranial pressure monitoring, demonstrating safe chronic implantation and reliable ICP measurements over extended periods. The device aims to replace bulky external ventricular drain monitoring with a chronically implantable pressure sensor that patients can wear without hospitalization.
Why it matters
Chronic hydrocephalus affects millions of patients who require lifelong ICP monitoring currently only possible through periodic hospital lumbar punctures or risky EVD placement. A chronically implantable discrete ICP sensor published in Nature Communications establishes clinical proof of concept and sets Kitea on a path to commercialize the most wanted neurodiagnostic implant in clinical neurology.
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trial